ArticleBlood neoplasia2026

Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.

Diana T Samuels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.